Frederick H. Hausheer

2.0k citations
40 papers · 1.5k indexed · h-index 18
Topics
Cancer therapeutics and mechanisms (10 papers)Cancer Treatment and Pharmacology (9 papers)Chemotherapy-induced organ toxicity mitigation (6 papers)

In The Last Decade

Frederick H. Hausheer

39 papers receiving 1.5k citations

Peers

Frederick H. Hausheer
Comparison fields: 5 of 104
  • Oncology 998
  • Molecular Biology 392
  • Dermatology 292
  • Pulmonary and Respiratory Medicine 251
  • Hematology 201
Replace M. Boisdron‐Celle with:
M. Boisdron‐Celle France
C. Peterson Sweden
Jamie L. Renbarger United States
M de Boer-Dennert Netherlands
Robert H. Earhart United States
Charity D. Scripture United States
Ursula Amstutz Switzerland
María Sereno Spain
Larry J. Schaaf United States
Zeina Nahleh United States
Frederick H. Hausheer relative to M. Boisdron‐Celle France M. Boisdron‐Celle's profile →
Citations per field
00.5×1.5×
M. Boisdron‐Celle · 1×
Citations per year

Countries citing papers authored by Frederick H. Hausheer

Since Specialization
Citations

This map shows the geographic impact of Frederick H. Hausheer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick H. Hausheer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick H. Hausheer more than expected).

Fields of papers citing papers by Frederick H. Hausheer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick H. Hausheer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick H. Hausheer. The network helps show where Frederick H. Hausheer may publish in the future.

Co-authorship network of co-authors of Frederick H. Hausheer

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick H. Hausheer. A scholar is included among the top collaborators of Frederick H. Hausheer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick H. Hausheer. Frederick H. Hausheer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 79
3 8
4 19
5 12
6 149
7 43
8
Valproic acid sensitizes human melanoma cells to karenitecin in vitro and in vivo
0
9 307
10 12
11 12
12 6
13 18
14 7
15 35
16 19
17 70
18 7
19 6
20 18

About Frederick H. Hausheer

Frederick H. Hausheer is a scholar working on Oncology, Computer Graphics and Computer-Aided Design and Anesthesiology and Pain Medicine, having authored 40 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (10 papers), Cancer Treatment and Pharmacology (9 papers) and Chemotherapy-induced organ toxicity mitigation (6 papers). The work is most often cited by research in Oncology (998 citations), Dermatology (292 citations) and Hematology (201 citations). Frederick H. Hausheer has collaborated with scholars based in United States, Netherlands and Japan. Frequent co-authors include John W. Yarbro, Stacey Bain, Richard L. Schilsky, Elmer Berghorn, Frank S. Lieberman, Epie Boven, Kathleen M. Foley, Yasuo Ohashi, Satoshi Morita and Ayano Takeuchi. Their work appears in journals such as Journal of the American Chemical Society, Cancer Research and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026